カテゴリ： 世界, 消費財/食品, QYResearch

グリコピロレート注射液の世界市場2023年：0.2mg/ml、0.4mg/2ml、1mg/5ml、4mg/20ml

■ 英語タイトル：Global Glycopyrrolate Injection Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8776）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8776
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：119
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[グリコピロレート注射液の世界市場2023年：0.2mg/ml、0.4mg/2ml、1mg/5ml、4mg/20ml]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はグリコピロレート注射液のグローバル市場について調査・分析し、世界のグリコピロレート注射液市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（0.2mg/ml、0.4mg/2ml、1mg/5ml、4mg/20ml）、用途別セグメント分析（病院、クリニック、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Accord Healthcare、Advanz Pharma、American Regent、Amneal Pharmaceuticals、Apotex、BE Pharmaceuticals、BluePoint Laboratories、Caplin Steriles、Civica、Fresenius Kabi、Gland Pharma、Hikma、Khandelwal Laboratories、Meitheal、Nivagen Pharmaceuticals、NorthStar Rx、Sandoz、Solco Healthcare、SteriMax、Xiromed、AuroMedics Pharma、Par Pharmaceutical、Piramal Critical Care、Somerset Therapeutics、West-ward Pharmaceutical、Zydus Pharmaceuticals、Hengrui Pharmaceuticals、Jiabo Pharmaceutical、Easton Biopharmaceuticalsなどが含まれています。グリコピロレート注射液のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、グリコピロレート注射液市場規模を算出する際に考慮しました。

・グリコピロレート注射液市場の概要
- 製品の定義
- グリコピロレート注射液の種類別セグメント
- 世界のグリコピロレート注射液市場規模：タイプ別分析（0.2mg/ml、0.4mg/2ml、1mg/5ml、4mg/20ml）
- グリコピロレート注射液の用途別セグメント
- 世界のグリコピロレート注射液市場規模：用途別分析（病院、クリニック、その他）
- 世界のグリコピロレート注射液市場規模予測（2018年-2029年）
- グリコピロレート注射液の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- グリコピロレート注射液市場の競争状況およびトレンド

・グリコピロレート注射液の地域別市場規模
- 北米のグリコピロレート注射液市場規模（2018年-2029年）
- 米国のグリコピロレート注射液市場規模（2018年-2029年）
- ヨーロッパのグリコピロレート注射液市場規模（2018年-2029年）
- アジア太平洋のグリコピロレート注射液市場規模（2018年-2029年）
- 中国のグリコピロレート注射液市場規模（2018年-2029年）
- 日本のグリコピロレート注射液市場規模（2018年-2029年）
- 韓国のグリコピロレート注射液市場規模（2018年-2029年）
- インドのグリコピロレート注射液市場規模（2018年-2029年）
- オーストラリアのグリコピロレート注射液市場規模（2018年-2029年）
- 中南米のグリコピロレート注射液市場規模（2018年-2029年）
- 中東・アフリカのグリコピロレート注射液市場規模（2018年-2029年）

・種類別セグメント：0.2mg/ml、0.4mg/2ml、1mg/5ml、4mg/20ml
- 世界のグリコピロレート注射液のタイプ別販売量（2018年-2023年）
- 世界のグリコピロレート注射液のタイプ別売上（2018年-2023年）
- 世界のグリコピロレート注射液のタイプ別価格

・用途別セグメント：病院、クリニック、その他
- 世界のグリコピロレート注射液の用途別販売量（2018年-2023年）
- 世界のグリコピロレート注射液の用途別売上（2018年-2023年）
- 世界のグリコピロレート注射液の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Accord Healthcare、Advanz Pharma、American Regent、Amneal Pharmaceuticals、Apotex、BE Pharmaceuticals、BluePoint Laboratories、Caplin Steriles、Civica、Fresenius Kabi、Gland Pharma、Hikma、Khandelwal Laboratories、Meitheal、Nivagen Pharmaceuticals、NorthStar Rx、Sandoz、Solco Healthcare、SteriMax、Xiromed、AuroMedics Pharma、Par Pharmaceutical、Piramal Critical Care、Somerset Therapeutics、West-ward Pharmaceutical、Zydus Pharmaceuticals、Hengrui Pharmaceuticals、Jiabo Pharmaceutical、Easton Biopharmaceuticals

・産業チェーンと販売チャネルの分析
- グリコピロレート注射液産業チェーン分析
- グリコピロレート注射液の主要原材料
- グリコピロレート注射液の販売チャネル
- グリコピロレート注射液のディストリビューター
- グリコピロレート注射液の主要顧客

・グリコピロレート注射液市場ダイナミクス
- グリコピロレート注射液の業界動向
- グリコピロレート注射液市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Glycopyrrolate Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Glycopyrrolate Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Glycopyrrolate Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Glycopyrrolate Injection include Accord Healthcare, Advanz Pharma, American Regent, Amneal Pharmaceuticals, Apotex, BE Pharmaceuticals, BluePoint Laboratories, Caplin Steriles and Civica, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glycopyrrolate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycopyrrolate Injection.
The Glycopyrrolate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Glycopyrrolate Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycopyrrolate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Accord Healthcare
Advanz Pharma
American Regent
Amneal Pharmaceuticals
Apotex
BE Pharmaceuticals
BluePoint Laboratories
Caplin Steriles
Civica
Fresenius Kabi
Gland Pharma
Hikma
Khandelwal Laboratories
Meitheal
Nivagen Pharmaceuticals
NorthStar Rx
Sandoz
Solco Healthcare
SteriMax
Xiromed
AuroMedics Pharma
Par Pharmaceutical
Piramal Critical Care
Somerset Therapeutics
West-ward Pharmaceutical
Zydus Pharmaceuticals
Hengrui Pharmaceuticals
Jiabo Pharmaceutical
Easton Biopharmaceuticals
Segment by Type
0.2mg/ml
0.4mg/2ml
1mg/5ml
4mg/20ml
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glycopyrrolate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glycopyrrolate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Glycopyrrolate Injection Market Overview
1.1 Product Overview and Scope of Glycopyrrolate Injection
1.2 Glycopyrrolate Injection Segment by Type
1.2.1 Global Glycopyrrolate Injection Market Value Comparison by Type (2023-2029)
1.2.2 0.2mg/ml
1.2.3 0.4mg/2ml
1.2.4 1mg/5ml
1.2.5 4mg/20ml
1.3 Glycopyrrolate Injection Segment by Application
1.3.1 Global Glycopyrrolate Injection Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Glycopyrrolate Injection Market Size Estimates and Forecasts
1.4.1 Global Glycopyrrolate Injection Revenue 2018-2029
1.4.2 Global Glycopyrrolate Injection Sales 2018-2029
1.4.3 Global Glycopyrrolate Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Glycopyrrolate Injection Market Competition by Manufacturers
2.1 Global Glycopyrrolate Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Glycopyrrolate Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Glycopyrrolate Injection Average Price by Manufacturers (2018-2023)
2.4 Global Glycopyrrolate Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Glycopyrrolate Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glycopyrrolate Injection, Product Type & Application
2.7 Glycopyrrolate Injection Market Competitive Situation and Trends
2.7.1 Glycopyrrolate Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glycopyrrolate Injection Players Market Share by Revenue
2.7.3 Global Glycopyrrolate Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glycopyrrolate Injection Retrospective Market Scenario by Region
3.1 Global Glycopyrrolate Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Glycopyrrolate Injection Global Glycopyrrolate Injection Sales by Region: 2018-2029
3.2.1 Global Glycopyrrolate Injection Sales by Region: 2018-2023
3.2.2 Global Glycopyrrolate Injection Sales by Region: 2024-2029
3.3 Global Glycopyrrolate Injection Global Glycopyrrolate Injection Revenue by Region: 2018-2029
3.3.1 Global Glycopyrrolate Injection Revenue by Region: 2018-2023
3.3.2 Global Glycopyrrolate Injection Revenue by Region: 2024-2029
3.4 North America Glycopyrrolate Injection Market Facts & Figures by Country
3.4.1 North America Glycopyrrolate Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Glycopyrrolate Injection Sales by Country (2018-2029)
3.4.3 North America Glycopyrrolate Injection Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glycopyrrolate Injection Market Facts & Figures by Country
3.5.1 Europe Glycopyrrolate Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Glycopyrrolate Injection Sales by Country (2018-2029)
3.5.3 Europe Glycopyrrolate Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glycopyrrolate Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Glycopyrrolate Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Glycopyrrolate Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Glycopyrrolate Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glycopyrrolate Injection Market Facts & Figures by Country
3.7.1 Latin America Glycopyrrolate Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Glycopyrrolate Injection Sales by Country (2018-2029)
3.7.3 Latin America Glycopyrrolate Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glycopyrrolate Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Glycopyrrolate Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Glycopyrrolate Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Glycopyrrolate Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Glycopyrrolate Injection Sales by Type (2018-2029)
4.1.1 Global Glycopyrrolate Injection Sales by Type (2018-2023)
4.1.2 Global Glycopyrrolate Injection Sales by Type (2024-2029)
4.1.3 Global Glycopyrrolate Injection Sales Market Share by Type (2018-2029)
4.2 Global Glycopyrrolate Injection Revenue by Type (2018-2029)
4.2.1 Global Glycopyrrolate Injection Revenue by Type (2018-2023)
4.2.2 Global Glycopyrrolate Injection Revenue by Type (2024-2029)
4.2.3 Global Glycopyrrolate Injection Revenue Market Share by Type (2018-2029)
4.3 Global Glycopyrrolate Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Glycopyrrolate Injection Sales by Application (2018-2029)
5.1.1 Global Glycopyrrolate Injection Sales by Application (2018-2023)
5.1.2 Global Glycopyrrolate Injection Sales by Application (2024-2029)
5.1.3 Global Glycopyrrolate Injection Sales Market Share by Application (2018-2029)
5.2 Global Glycopyrrolate Injection Revenue by Application (2018-2029)
5.2.1 Global Glycopyrrolate Injection Revenue by Application (2018-2023)
5.2.2 Global Glycopyrrolate Injection Revenue by Application (2024-2029)
5.2.3 Global Glycopyrrolate Injection Revenue Market Share by Application (2018-2029)
5.3 Global Glycopyrrolate Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Accord Healthcare
6.1.1 Accord Healthcare Corporation Information
6.1.2 Accord Healthcare Description and Business Overview
6.1.3 Accord Healthcare Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Accord Healthcare Glycopyrrolate Injection Product Portfolio
6.1.5 Accord Healthcare Recent Developments/Updates
6.2 Advanz Pharma
6.2.1 Advanz Pharma Corporation Information
6.2.2 Advanz Pharma Description and Business Overview
6.2.3 Advanz Pharma Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Advanz Pharma Glycopyrrolate Injection Product Portfolio
6.2.5 Advanz Pharma Recent Developments/Updates
6.3 American Regent
6.3.1 American Regent Corporation Information
6.3.2 American Regent Description and Business Overview
6.3.3 American Regent Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 American Regent Glycopyrrolate Injection Product Portfolio
6.3.5 American Regent Recent Developments/Updates
6.4 Amneal Pharmaceuticals
6.4.1 Amneal Pharmaceuticals Corporation Information
6.4.2 Amneal Pharmaceuticals Description and Business Overview
6.4.3 Amneal Pharmaceuticals Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Amneal Pharmaceuticals Glycopyrrolate Injection Product Portfolio
6.4.5 Amneal Pharmaceuticals Recent Developments/Updates
6.5 Apotex
6.5.1 Apotex Corporation Information
6.5.2 Apotex Description and Business Overview
6.5.3 Apotex Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Apotex Glycopyrrolate Injection Product Portfolio
6.5.5 Apotex Recent Developments/Updates
6.6 BE Pharmaceuticals
6.6.1 BE Pharmaceuticals Corporation Information
6.6.2 BE Pharmaceuticals Description and Business Overview
6.6.3 BE Pharmaceuticals Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 BE Pharmaceuticals Glycopyrrolate Injection Product Portfolio
6.6.5 BE Pharmaceuticals Recent Developments/Updates
6.7 BluePoint Laboratories
6.6.1 BluePoint Laboratories Corporation Information
6.6.2 BluePoint Laboratories Description and Business Overview
6.6.3 BluePoint Laboratories Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BluePoint Laboratories Glycopyrrolate Injection Product Portfolio
6.7.5 BluePoint Laboratories Recent Developments/Updates
6.8 Caplin Steriles
6.8.1 Caplin Steriles Corporation Information
6.8.2 Caplin Steriles Description and Business Overview
6.8.3 Caplin Steriles Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Caplin Steriles Glycopyrrolate Injection Product Portfolio
6.8.5 Caplin Steriles Recent Developments/Updates
6.9 Civica
6.9.1 Civica Corporation Information
6.9.2 Civica Description and Business Overview
6.9.3 Civica Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Civica Glycopyrrolate Injection Product Portfolio
6.9.5 Civica Recent Developments/Updates
6.10 Fresenius Kabi
6.10.1 Fresenius Kabi Corporation Information
6.10.2 Fresenius Kabi Description and Business Overview
6.10.3 Fresenius Kabi Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Fresenius Kabi Glycopyrrolate Injection Product Portfolio
6.10.5 Fresenius Kabi Recent Developments/Updates
6.11 Gland Pharma
6.11.1 Gland Pharma Corporation Information
6.11.2 Gland Pharma Glycopyrrolate Injection Description and Business Overview
6.11.3 Gland Pharma Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Gland Pharma Glycopyrrolate Injection Product Portfolio
6.11.5 Gland Pharma Recent Developments/Updates
6.12 Hikma
6.12.1 Hikma Corporation Information
6.12.2 Hikma Glycopyrrolate Injection Description and Business Overview
6.12.3 Hikma Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Hikma Glycopyrrolate Injection Product Portfolio
6.12.5 Hikma Recent Developments/Updates
6.13 Khandelwal Laboratories
6.13.1 Khandelwal Laboratories Corporation Information
6.13.2 Khandelwal Laboratories Glycopyrrolate Injection Description and Business Overview
6.13.3 Khandelwal Laboratories Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Khandelwal Laboratories Glycopyrrolate Injection Product Portfolio
6.13.5 Khandelwal Laboratories Recent Developments/Updates
6.14 Meitheal
6.14.1 Meitheal Corporation Information
6.14.2 Meitheal Glycopyrrolate Injection Description and Business Overview
6.14.3 Meitheal Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Meitheal Glycopyrrolate Injection Product Portfolio
6.14.5 Meitheal Recent Developments/Updates
6.15 Nivagen Pharmaceuticals
6.15.1 Nivagen Pharmaceuticals Corporation Information
6.15.2 Nivagen Pharmaceuticals Glycopyrrolate Injection Description and Business Overview
6.15.3 Nivagen Pharmaceuticals Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Nivagen Pharmaceuticals Glycopyrrolate Injection Product Portfolio
6.15.5 Nivagen Pharmaceuticals Recent Developments/Updates
6.16 NorthStar Rx
6.16.1 NorthStar Rx Corporation Information
6.16.2 NorthStar Rx Glycopyrrolate Injection Description and Business Overview
6.16.3 NorthStar Rx Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.16.4 NorthStar Rx Glycopyrrolate Injection Product Portfolio
6.16.5 NorthStar Rx Recent Developments/Updates
6.17 Sandoz
6.17.1 Sandoz Corporation Information
6.17.2 Sandoz Glycopyrrolate Injection Description and Business Overview
6.17.3 Sandoz Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Sandoz Glycopyrrolate Injection Product Portfolio
6.17.5 Sandoz Recent Developments/Updates
6.18 Solco Healthcare
6.18.1 Solco Healthcare Corporation Information
6.18.2 Solco Healthcare Glycopyrrolate Injection Description and Business Overview
6.18.3 Solco Healthcare Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Solco Healthcare Glycopyrrolate Injection Product Portfolio
6.18.5 Solco Healthcare Recent Developments/Updates
6.19 SteriMax
6.19.1 SteriMax Corporation Information
6.19.2 SteriMax Glycopyrrolate Injection Description and Business Overview
6.19.3 SteriMax Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.19.4 SteriMax Glycopyrrolate Injection Product Portfolio
6.19.5 SteriMax Recent Developments/Updates
6.20 Xiromed
6.20.1 Xiromed Corporation Information
6.20.2 Xiromed Glycopyrrolate Injection Description and Business Overview
6.20.3 Xiromed Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Xiromed Glycopyrrolate Injection Product Portfolio
6.20.5 Xiromed Recent Developments/Updates
6.21 AuroMedics Pharma
6.21.1 AuroMedics Pharma Corporation Information
6.21.2 AuroMedics Pharma Glycopyrrolate Injection Description and Business Overview
6.21.3 AuroMedics Pharma Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.21.4 AuroMedics Pharma Glycopyrrolate Injection Product Portfolio
6.21.5 AuroMedics Pharma Recent Developments/Updates
6.22 Par Pharmaceutical
6.22.1 Par Pharmaceutical Corporation Information
6.22.2 Par Pharmaceutical Glycopyrrolate Injection Description and Business Overview
6.22.3 Par Pharmaceutical Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Par Pharmaceutical Glycopyrrolate Injection Product Portfolio
6.22.5 Par Pharmaceutical Recent Developments/Updates
6.23 Piramal Critical Care
6.23.1 Piramal Critical Care Corporation Information
6.23.2 Piramal Critical Care Glycopyrrolate Injection Description and Business Overview
6.23.3 Piramal Critical Care Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Piramal Critical Care Glycopyrrolate Injection Product Portfolio
6.23.5 Piramal Critical Care Recent Developments/Updates
6.24 Somerset Therapeutics
6.24.1 Somerset Therapeutics Corporation Information
6.24.2 Somerset Therapeutics Glycopyrrolate Injection Description and Business Overview
6.24.3 Somerset Therapeutics Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Somerset Therapeutics Glycopyrrolate Injection Product Portfolio
6.24.5 Somerset Therapeutics Recent Developments/Updates
6.25 West-ward Pharmaceutical
6.25.1 West-ward Pharmaceutical Corporation Information
6.25.2 West-ward Pharmaceutical Glycopyrrolate Injection Description and Business Overview
6.25.3 West-ward Pharmaceutical Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.25.4 West-ward Pharmaceutical Glycopyrrolate Injection Product Portfolio
6.25.5 West-ward Pharmaceutical Recent Developments/Updates
6.26 Zydus Pharmaceuticals
6.26.1 Zydus Pharmaceuticals Corporation Information
6.26.2 Zydus Pharmaceuticals Glycopyrrolate Injection Description and Business Overview
6.26.3 Zydus Pharmaceuticals Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.26.4 Zydus Pharmaceuticals Glycopyrrolate Injection Product Portfolio
6.26.5 Zydus Pharmaceuticals Recent Developments/Updates
6.27 Hengrui Pharmaceuticals
6.27.1 Hengrui Pharmaceuticals Corporation Information
6.27.2 Hengrui Pharmaceuticals Glycopyrrolate Injection Description and Business Overview
6.27.3 Hengrui Pharmaceuticals Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.27.4 Hengrui Pharmaceuticals Glycopyrrolate Injection Product Portfolio
6.27.5 Hengrui Pharmaceuticals Recent Developments/Updates
6.28 Jiabo Pharmaceutical
6.28.1 Jiabo Pharmaceutical Corporation Information
6.28.2 Jiabo Pharmaceutical Glycopyrrolate Injection Description and Business Overview
6.28.3 Jiabo Pharmaceutical Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.28.4 Jiabo Pharmaceutical Glycopyrrolate Injection Product Portfolio
6.28.5 Jiabo Pharmaceutical Recent Developments/Updates
6.29 Easton Biopharmaceuticals
6.29.1 Easton Biopharmaceuticals Corporation Information
6.29.2 Easton Biopharmaceuticals Glycopyrrolate Injection Description and Business Overview
6.29.3 Easton Biopharmaceuticals Glycopyrrolate Injection Sales, Revenue and Gross Margin (2018-2023)
6.29.4 Easton Biopharmaceuticals Glycopyrrolate Injection Product Portfolio
6.29.5 Easton Biopharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glycopyrrolate Injection Industry Chain Analysis
7.2 Glycopyrrolate Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glycopyrrolate Injection Production Mode & Process
7.4 Glycopyrrolate Injection Sales and Marketing
7.4.1 Glycopyrrolate Injection Sales Channels
7.4.2 Glycopyrrolate Injection Distributors
7.5 Glycopyrrolate Injection Customers
8 Glycopyrrolate Injection Market Dynamics
8.1 Glycopyrrolate Injection Industry Trends
8.2 Glycopyrrolate Injection Market Drivers
8.3 Glycopyrrolate Injection Market Challenges
8.4 Glycopyrrolate Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Glycopyrrolate Injection Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Glycopyrrolate Injection Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Glycopyrrolate Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Glycopyrrolate Injection Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Glycopyrrolate Injection Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Glycopyrrolate Injection Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Glycopyrrolate Injection Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Glycopyrrolate Injection Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Glycopyrrolate Injection, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Glycopyrrolate Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Glycopyrrolate Injection, Product Type & Application
Table 12. Global Key Manufacturers of Glycopyrrolate Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Glycopyrrolate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycopyrrolate Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Glycopyrrolate Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Glycopyrrolate Injection Sales by Region (2018-2023) & (K Units)
Table 18. Global Glycopyrrolate Injection Sales Market Share by Region (2018-2023)
Table 19. Global Glycopyrrolate Injection Sales by Region (2024-2029) & (K Units)
Table 20. Global Glycopyrrolate Injection Sales Market Share by Region (2024-2029)
Table 21. Global Glycopyrrolate Injection Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Glycopyrrolate Injection Revenue Market Share by Region (2018-2023)
Table 23. Global Glycopyrrolate Injection Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Glycopyrrolate Injection Revenue Market Share by Region (2024-2029)
Table 25. North America Glycopyrrolate Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Glycopyrrolate Injection Sales by Country (2018-2023) & (K Units)
Table 27. North America Glycopyrrolate Injection Sales by Country (2024-2029) & (K Units)
Table 28. North America Glycopyrrolate Injection Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Glycopyrrolate Injection Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Glycopyrrolate Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Glycopyrrolate Injection Sales by Country (2018-2023) & (K Units)
Table 32. Europe Glycopyrrolate Injection Sales by Country (2024-2029) & (K Units)
Table 33. Europe Glycopyrrolate Injection Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Glycopyrrolate Injection Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Glycopyrrolate Injection Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Glycopyrrolate Injection Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Glycopyrrolate Injection Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Glycopyrrolate Injection Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Glycopyrrolate Injection Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Glycopyrrolate Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Glycopyrrolate Injection Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Glycopyrrolate Injection Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Glycopyrrolate Injection Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Glycopyrrolate Injection Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Glycopyrrolate Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Glycopyrrolate Injection Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Glycopyrrolate Injection Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Glycopyrrolate Injection Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Glycopyrrolate Injection Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Glycopyrrolate Injection Sales (K Units) by Type (2018-2023)
Table 51. Global Glycopyrrolate Injection Sales (K Units) by Type (2024-2029)
Table 52. Global Glycopyrrolate Injection Sales Market Share by Type (2018-2023)
Table 53. Global Glycopyrrolate Injection Sales Market Share by Type (2024-2029)
Table 54. Global Glycopyrrolate Injection Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Glycopyrrolate Injection Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Glycopyrrolate Injection Revenue Market Share by Type (2018-2023)
Table 57. Global Glycopyrrolate Injection Revenue Market Share by Type (2024-2029)
Table 58. Global Glycopyrrolate Injection Price (US$/Unit) by Type (2018-2023)
Table 59. Global Glycopyrrolate Injection Price (US$/Unit) by Type (2024-2029)
Table 60. Global Glycopyrrolate Injection Sales (K Units) by Application (2018-2023)
Table 61. Global Glycopyrrolate Injection Sales (K Units) by Application (2024-2029)
Table 62. Global Glycopyrrolate Injection Sales Market Share by Application (2018-2023)
Table 63. Global Glycopyrrolate Injection Sales Market Share by Application (2024-2029)
Table 64. Global Glycopyrrolate Injection Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Glycopyrrolate Injection Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Glycopyrrolate Injection Revenue Market Share by Application (2018-2023)
Table 67. Global Glycopyrrolate Injection Revenue Market Share by Application (2024-2029)
Table 68. Global Glycopyrrolate Injection Price (US$/Unit) by Application (2018-2023)
Table 69. Global Glycopyrrolate Injection Price (US$/Unit) by Application (2024-2029)
Table 70. Accord Healthcare Corporation Information
Table 71. Accord Healthcare Description and Business Overview
Table 72. Accord Healthcare Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Accord Healthcare Glycopyrrolate Injection Product
Table 74. Accord Healthcare Recent Developments/Updates
Table 75. Advanz Pharma Corporation Information
Table 76. Advanz Pharma Description and Business Overview
Table 77. Advanz Pharma Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Advanz Pharma Glycopyrrolate Injection Product
Table 79. Advanz Pharma Recent Developments/Updates
Table 80. American Regent Corporation Information
Table 81. American Regent Description and Business Overview
Table 82. American Regent Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. American Regent Glycopyrrolate Injection Product
Table 84. American Regent Recent Developments/Updates
Table 85. Amneal Pharmaceuticals Corporation Information
Table 86. Amneal Pharmaceuticals Description and Business Overview
Table 87. Amneal Pharmaceuticals Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Amneal Pharmaceuticals Glycopyrrolate Injection Product
Table 89. Amneal Pharmaceuticals Recent Developments/Updates
Table 90. Apotex Corporation Information
Table 91. Apotex Description and Business Overview
Table 92. Apotex Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Apotex Glycopyrrolate Injection Product
Table 94. Apotex Recent Developments/Updates
Table 95. BE Pharmaceuticals Corporation Information
Table 96. BE Pharmaceuticals Description and Business Overview
Table 97. BE Pharmaceuticals Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. BE Pharmaceuticals Glycopyrrolate Injection Product
Table 99. BE Pharmaceuticals Recent Developments/Updates
Table 100. BluePoint Laboratories Corporation Information
Table 101. BluePoint Laboratories Description and Business Overview
Table 102. BluePoint Laboratories Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. BluePoint Laboratories Glycopyrrolate Injection Product
Table 104. BluePoint Laboratories Recent Developments/Updates
Table 105. Caplin Steriles Corporation Information
Table 106. Caplin Steriles Description and Business Overview
Table 107. Caplin Steriles Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Caplin Steriles Glycopyrrolate Injection Product
Table 109. Caplin Steriles Recent Developments/Updates
Table 110. Civica Corporation Information
Table 111. Civica Description and Business Overview
Table 112. Civica Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Civica Glycopyrrolate Injection Product
Table 114. Civica Recent Developments/Updates
Table 115. Fresenius Kabi Corporation Information
Table 116. Fresenius Kabi Description and Business Overview
Table 117. Fresenius Kabi Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Fresenius Kabi Glycopyrrolate Injection Product
Table 119. Fresenius Kabi Recent Developments/Updates
Table 120. Gland Pharma Corporation Information
Table 121. Gland Pharma Description and Business Overview
Table 122. Gland Pharma Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Gland Pharma Glycopyrrolate Injection Product
Table 124. Gland Pharma Recent Developments/Updates
Table 125. Hikma Corporation Information
Table 126. Hikma Description and Business Overview
Table 127. Hikma Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Hikma Glycopyrrolate Injection Product
Table 129. Hikma Recent Developments/Updates
Table 130. Khandelwal Laboratories Corporation Information
Table 131. Khandelwal Laboratories Description and Business Overview
Table 132. Khandelwal Laboratories Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Khandelwal Laboratories Glycopyrrolate Injection Product
Table 134. Khandelwal Laboratories Recent Developments/Updates
Table 135. Meitheal Corporation Information
Table 136. Meitheal Description and Business Overview
Table 137. Meitheal Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Meitheal Glycopyrrolate Injection Product
Table 139. Meitheal Recent Developments/Updates
Table 140. Nivagen Pharmaceuticals Corporation Information
Table 141. Nivagen Pharmaceuticals Description and Business Overview
Table 142. Nivagen Pharmaceuticals Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Nivagen Pharmaceuticals Glycopyrrolate Injection Product
Table 144. Nivagen Pharmaceuticals Recent Developments/Updates
Table 145. NorthStar Rx Corporation Information
Table 146. NorthStar Rx Description and Business Overview
Table 147. NorthStar Rx Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. NorthStar Rx Glycopyrrolate Injection Product
Table 149. NorthStar Rx Recent Developments/Updates
Table 150. Sandoz Corporation Information
Table 151. Sandoz Description and Business Overview
Table 152. Sandoz Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Sandoz Glycopyrrolate Injection Product
Table 154. Sandoz Recent Developments/Updates
Table 155. Solco Healthcare Corporation Information
Table 156. Solco Healthcare Description and Business Overview
Table 157. Solco Healthcare Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Solco Healthcare Glycopyrrolate Injection Product
Table 159. Solco Healthcare Recent Developments/Updates
Table 160. SteriMax Corporation Information
Table 161. SteriMax Description and Business Overview
Table 162. SteriMax Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. SteriMax Glycopyrrolate Injection Product
Table 164. SteriMax Recent Developments/Updates
Table 165. Xiromed Corporation Information
Table 166. Xiromed Description and Business Overview
Table 167. Xiromed Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Xiromed Glycopyrrolate Injection Product
Table 169. Xiromed Recent Developments/Updates
Table 170. AuroMedics Pharma Corporation Information
Table 171. AuroMedics Pharma Description and Business Overview
Table 172. AuroMedics Pharma Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 173. AuroMedics Pharma Glycopyrrolate Injection Product
Table 174. AuroMedics Pharma Recent Developments/Updates
Table 175. Par Pharmaceutical Corporation Information
Table 176. Par Pharmaceutical Description and Business Overview
Table 177. Par Pharmaceutical Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 178. Par Pharmaceutical Glycopyrrolate Injection Product
Table 179. Par Pharmaceutical Recent Developments/Updates
Table 180. Piramal Critical Care Corporation Information
Table 181. Piramal Critical Care Description and Business Overview
Table 182. Piramal Critical Care Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 183. Piramal Critical Care Glycopyrrolate Injection Product
Table 184. Piramal Critical Care Recent Developments/Updates
Table 185. Somerset Therapeutics Corporation Information
Table 186. Somerset Therapeutics Description and Business Overview
Table 187. Somerset Therapeutics Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 188. Somerset Therapeutics Glycopyrrolate Injection Product
Table 189. Somerset Therapeutics Recent Developments/Updates
Table 190. West-ward Pharmaceutical Corporation Information
Table 191. West-ward Pharmaceutical Description and Business Overview
Table 192. West-ward Pharmaceutical Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 193. West-ward Pharmaceutical Glycopyrrolate Injection Product
Table 194. West-ward Pharmaceutical Recent Developments/Updates
Table 195. Zydus Pharmaceuticals Corporation Information
Table 196. Zydus Pharmaceuticals Description and Business Overview
Table 197. Zydus Pharmaceuticals Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 198. Zydus Pharmaceuticals Glycopyrrolate Injection Product
Table 199. Zydus Pharmaceuticals Recent Developments/Updates
Table 200. Hengrui Pharmaceuticals Corporation Information
Table 201. Hengrui Pharmaceuticals Description and Business Overview
Table 202. Hengrui Pharmaceuticals Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 203. Hengrui Pharmaceuticals Glycopyrrolate Injection Product
Table 204. Hengrui Pharmaceuticals Recent Developments/Updates
Table 205. Jiabo Pharmaceutical Corporation Information
Table 206. Jiabo Pharmaceutical Description and Business Overview
Table 207. Jiabo Pharmaceutical Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 208. Jiabo Pharmaceutical Glycopyrrolate Injection Product
Table 209. Jiabo Pharmaceutical Recent Developments/Updates
Table 210. Easton Biopharmaceuticals Corporation Information
Table 211. Easton Biopharmaceuticals Description and Business Overview
Table 212. Easton Biopharmaceuticals Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 213. Easton Biopharmaceuticals Glycopyrrolate Injection Product
Table 214. Easton Biopharmaceuticals Recent Developments/Updates
Table 215. Key Raw Materials Lists
Table 216. Raw Materials Key Suppliers Lists
Table 217. Glycopyrrolate Injection Distributors List
Table 218. Glycopyrrolate Injection Customers List
Table 219. Glycopyrrolate Injection Market Trends
Table 220. Glycopyrrolate Injection Market Drivers
Table 221. Glycopyrrolate Injection Market Challenges
Table 222. Glycopyrrolate Injection Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Glycopyrrolate Injection
Figure 2. Global Glycopyrrolate Injection Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Glycopyrrolate Injection Market Share by Type in 2022 & 2029
Figure 4. 0.2mg/ml Product Picture
Figure 5. 0.4mg/2ml Product Picture
Figure 6. 1mg/5ml Product Picture
Figure 7. 4mg/20ml Product Picture
Figure 8. Global Glycopyrrolate Injection Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Glycopyrrolate Injection Market Share by Application in 2022 & 2029
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Others
Figure 13. Global Glycopyrrolate Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Glycopyrrolate Injection Market Size (2018-2029) & (US$ Million)
Figure 15. Global Glycopyrrolate Injection Sales (2018-2029) & (K Units)
Figure 16. Global Glycopyrrolate Injection Average Price (US$/Unit) & (2018-2029)
Figure 17. Glycopyrrolate Injection Report Years Considered
Figure 18. Glycopyrrolate Injection Sales Share by Manufacturers in 2022
Figure 19. Global Glycopyrrolate Injection Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Glycopyrrolate Injection Players: Market Share by Revenue in 2022
Figure 21. Glycopyrrolate Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Glycopyrrolate Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Glycopyrrolate Injection Sales Market Share by Country (2018-2029)
Figure 24. North America Glycopyrrolate Injection Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Glycopyrrolate Injection Sales Market Share by Country (2018-2029)
Figure 28. Europe Glycopyrrolate Injection Revenue Market Share by Country (2018-2029)
Figure 29. Germany Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Glycopyrrolate Injection Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Glycopyrrolate Injection Revenue Market Share by Region (2018-2029)
Figure 36. China Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Taiwan Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Philippines Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Glycopyrrolate Injection Sales Market Share by Country (2018-2029)
Figure 47. Latin America Glycopyrrolate Injection Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Glycopyrrolate Injection Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Glycopyrrolate Injection Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. U.A.E Glycopyrrolate Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Glycopyrrolate Injection by Type (2018-2029)
Figure 57. Global Revenue Market Share of Glycopyrrolate Injection by Type (2018-2029)
Figure 58. Global Glycopyrrolate Injection Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Glycopyrrolate Injection by Application (2018-2029)
Figure 60. Global Revenue Market Share of Glycopyrrolate Injection by Application (2018-2029)
Figure 61. Global Glycopyrrolate Injection Price (US$/Unit) by Application (2018-2029)
Figure 62. Glycopyrrolate Injection Value Chain
Figure 63. Glycopyrrolate Injection Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • タンパク質濃縮器の世界市場2023年：1mL以下、1mL～5mL、5mL～20mL、20mL～100mL
  • 限外ろ過スピンカラムの世界市場2023年：1mL以下、1mL～5mL、5mL～20mL、20mL～100mL
  • ガドテリックアシッドメグルミン塩注射液の世界市場2023年：3.769g/10ml、5.654g/15ml、7.538g/20ml
  • 低ホウケイ酸ガラスアンプルの世界市場2023年：1-5ml、6-10ml、11-15ml、15-20ml、21-25ml、25-30ml
  • 高張海水鼻スプレーの世界市場2023年：20ml、50ml、100ml、200ml、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8776 )"グリコピロレート注射液の世界市場2023年：0.2mg/ml、0.4mg/2ml、1mg/5ml、4mg/20ml" (英文：Global Glycopyrrolate Injection Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。